World Pharma Today

Neuland Laboratories Expands Peptide Manufacturing Capacity

Yuvraj — Fri, 13 Mar 2026 11:15:19 +0000

Neuland Laboratories is preparing to launch a new commercial peptide manufacturing facility at its 17-acre Bonthapally manufacturing campus, with the first phase expected to become operational in the summer of this year. The project forms part of a broader expansion plan aimed at scaling peptide manufacturing capabilities in response to rising client demand. Once complete, […]

The post Neuland Laboratories Expands Peptide Manufacturing Capacity first appeared on World Pharma Today.

Syntegon and Lyocontract: Growing Together

Yuvraj — Fri, 13 Mar 2026 11:12:12 +0000

Groundbreaking ceremony for 50-million-euro investment at LYOCONTRACT in Ilsenburg, Germany Complete vial line from Syntegon for freeze-dried pharmaceuticals Close partnership and seamless processes as the key to mutual success Demand for freeze-dried parenteral products in vials is increasing steadily. This also applies to contract manufacturer LYOCONTRACT, which has been producing in Ilsenburg, Germany, since 2012. […]

The post Syntegon and Lyocontract: Growing Together first appeared on World Pharma Today.

How to Find More Affordable Cancer Medication

Yuvraj — Fri, 13 Mar 2026 06:08:16 +0000

Cancer treatment could set back patients by up to $20,000 per year, with the entire treatment duration possibly reaching more than a million dollars. Many who suffer from the condition are not only experiencing the physical and emotional pain it brings, but cancer has the potential to upend an entire family’s financial security. Medication alone […]

The post How to Find More Affordable Cancer Medication first appeared on World Pharma Today.

The Hidden Risks of Combining Alcohol and Decongestants

Yuvraj — Fri, 13 Mar 2026 06:07:45 +0000

We have all been there: a nagging head cold or sinus pressure hits right before a weekend plan or social gathering. It is incredibly tempting to take a Sudafed to clear your head and go out anyway, assuming a drink or two won’t hurt. However, even though pseudoephedrine (the active ingredient in Sudafed) is available […]

The post The Hidden Risks of Combining Alcohol and Decongestants first appeared on World Pharma Today.

US FDA Approves Leucovorin for Rare Autism-Like Disorder

Yuvraj — Thu, 12 Mar 2026 06:15:46 +0000

The U.S. Food and Drug Administration on Tuesday authorized the use of leucovorin, a long-established generic medicine, for the treatment of a rare genetic disorder associated with autism-like symptoms. The decision does not extend to children diagnosed with autism more broadly, despite earlier suggestions last year that the drug might help address autism symptoms. Regulators […]

The post US FDA Approves Leucovorin for Rare Autism-Like Disorder first appeared on World Pharma Today.

It’s Time for the 3rd Generation of Patient Recruitment

Yuvraj — Wed, 11 Mar 2026 13:28:04 +0000

Key Takeaways 80% of clinical trials experience enrolment delays and massive sunk costs with underperforming sites. Only 4% of US physicians participate in clinical research, leaving 96% of patients inaccessible under other HCPs’ care. Tokenization links Citeline’s proprietary data; specifically, 300+ million claims lives, 245+ million lab lives & 55 million+ EMR patient lives with 1.7+ million HCP national provider identifiers (NPIs). Direct-to-patient traditional advertising recruitment campaigns fail with complex protocol criteria, most commonly in oncology and rare disease protocols. Last-mile operationalization […]

The post It’s Time for the 3rd Generation of Patient Recruitment first appeared on World Pharma Today.

Regulatory Roadmap Set for UK Space-Based Drug Manufacturing

Yuvraj — Wed, 11 Mar 2026 12:11:47 +0000

The UK government and national regulators have introduced a coordinated regulatory roadmap aimed at enabling space-based drug manufacturing, marking a significant step toward commercialising drug production in microgravity environments. The initiative brings together the UK Space Agency, the Medicines and Healthcare products Regulatory Agency (MHRA), the Regulatory Innovation Office (RIO) within the Department for Science, […]

The post Regulatory Roadmap Set for UK Space-Based Drug Manufacturing first appeared on World Pharma Today.

Key Innovations in Pharmaceutical Software for Streamlining Production Processes

Yuvraj — Wed, 11 Mar 2026 09:26:38 +0000

The pharmaceutical industry is dynamically changing. So, technological advances are critical. This is because they enhance efficiencies in production. The demand for high-quality drugs is ever-increasing. This means pharmaceutical companies encounter different challenges. Among the most important answers to these problems is the development of pharmaceutical software. This solution has greatly reshaped the nature of […]

The post Key Innovations in Pharmaceutical Software for Streamlining Production Processes first appeared on World Pharma Today.

The War for Sales Talent in Life Sciences: How Leading Companies Are Building Commercial Teams for Growth

Yuvraj — Wed, 11 Mar 2026 09:14:02 +0000

The global life sciences industry must remain competitive to sustain growth. Attracting employees to sales teams may require new strategies in the coming year. Understanding how the biggest companies are building their commercial teams will help you make life sciences sales careers more appealing to long-term team members. Is the Life Sciences Industry Growing? The […]

The post The War for Sales Talent in Life Sciences: How Leading Companies Are Building Commercial Teams for Growth first appeared on World Pharma Today.

Enhertu Priority Review in HER2-Positive Early Breast Cancer

Yuvraj — Wed, 11 Mar 2026 08:14:38 +0000

The supplemental Biologics License Application – sBLA for Enhertu – trastuzumab deruxtecan by AstraZeneca and Daiichi Sankyo has been accepted as well as granted Priority Review in the U.S. when it comes to the treatment of adult patients with HER2‑positive early breast cancer who happen to have residual invasive disease after neoadjuvant HER2‑targeted therapy. Enhertu […]

The post Enhertu Priority Review in HER2-Positive Early Breast Cancer first appeared on World Pharma Today.